[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  SEC Filings Digest [@USCorpFilings](/creator/twitter/USCorpFilings) on x 4428 followers Created: 2025-07-23 13:45:06 UTC $ELEV Merger of Equals: On July 23, 2025, Elevation Oncology, Inc. completed a merger with Concentra Biosciences, after which it became a wholly owned subsidiary of Concentra, with shareholders receiving $XXXX per share plus contingent value rights. This merger follows a tender offer that saw XXXXXXXXXX shares, or approximately 67.09%, tendered by shareholders. XXX engagements  **Related Topics** [stocks](/topic/stocks) [corporate finance](/topic/corporate-finance) [$elev](/topic/$elev) [Post Link](https://x.com/USCorpFilings/status/1948016522586407348)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
SEC Filings Digest @USCorpFilings on x 4428 followers
Created: 2025-07-23 13:45:06 UTC
$ELEV Merger of Equals:
On July 23, 2025, Elevation Oncology, Inc. completed a merger with Concentra Biosciences, after which it became a wholly owned subsidiary of Concentra, with shareholders receiving $XXXX per share plus contingent value rights. This merger follows a tender offer that saw XXXXXXXXXX shares, or approximately 67.09%, tendered by shareholders.
XXX engagements
Related Topics stocks corporate finance $elev
/post/tweet::1948016522586407348